René Rückert, MD, MBA
Founder and Chief Executive Officer of eye.gnos consulting.
Medical doctor, Immunologist, board certified in biochemistry, and business leader with a MBA from a lading university in teh UK with more than 18 years’ in leadership roles in the pharma industry, as pharma consultant and in basic research. Previously established the Ophthalmology franchise for a Top10 Pharma company. Leader of the global ophthalmology clinical development for the market leader in Ophthalmology. Significant background in basic research and preclinical and clinical development as immunologist, with world-class publications cited more than 2000-times, avid university lecturer. Clinical leader for the latest blockbuster in retina therapy and as brand marketing and medical affair leader for a small molecule blockbuster. Preclinical and Phase 1-3 leader for small molecules and biologics in several indications in inflammatory and autoimmune diseases, prelaunch and launch management in ophthalmology and immunology. Extensive BD&L, inlicensing and outlicensing experience.
Assoc. Prof. Marion Munk, MD, PhD, FEBO
A leading global ophthalmologist with broad clinical interest, a focus on clinical research in retina, uveitis, age-related macular degeneration and cystoid macular edema applying state of the art imaging as optical coherence tomography and functional magnetic resonance tomography. Background in immunology and theoretical physics. Investigator of many global clinical trials, consultant to the pharmaceutical industry and avid teacher, lecturer and presenter in academic settings and Author of more than 250 publications/presentations.